why choose us

First received: December 15, 2023

Clinical Trial: Open-label, Decentralized Study of SPN-812 (Qelbree®) in Adults With ADHD and Mood Symptoms

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Attention-Deficit/Hyperactivity Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase IV, Open-Label, Decentralized Clinical Trial to Evaluate the Efficacy and Safety of Qelbree® in Adults With Attention-Deficit/Hyperactivity Disorder and Mood Symptoms

Brief Summary: Open label, flexible dose, decentralized clinical trial evaluating the efficacy and safety of SPN-812 in adults with ADHD and mood symptoms.

Read more